From rationing to rationality: an n-of-one trial service for off-label medicines for rare (neuromuscular) diseases

Benzer Materyaller

• Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
  Yazar:: Vrinten, Charlotte, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
  Yazar:: Vrinten, Charlotte, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis
  Yazar:: Stephanie S. Weinreich, ve diğerleri
  Baskı/Yayın Bilgisi: (2017-05-01)
• Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis
  Yazar:: Weinreich, Stephanie S., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
  Yazar:: van der Gronde, Toon, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)